Nima E

Nima Emami is an Investment Analyst at EcoR1 Capital, LLC, a San Francisco-based hedge fund specializing in biotechnology and life sciences. In this role, he is responsible for due diligence, financial analysis, and evaluation of value-oriented investment opportunities within the biotech sector. His investment focus is centered on companies pioneering innovation in therapeutics and drug development, supporting EcoR1 Capital’s mission to advance life-saving breakthroughs in the pharmaceutical industry.

Prior to joining EcoR1, Nima has served as Chairman at Avail Bio since early 2023 and as a technical advisor to several venture capital firms since 2019. His background combines hands-on experience in scientific research, executive leadership, and advisory capacities in biotech and health-related VC investments, underscoring his broad expertise at the intersection of biology, data science, and capital markets.

Nima holds a PhD in Biological and Medical Informatics from UCSF, a BS in Bioengineering and Electrical Engineering & Computer Science from UC Berkeley, and an AI Professional Program Certificate from Stanford University. With this academic foundation, he brings deep quantitative and multidisciplinary analytical skills to his role, supporting rigorous diligence and investment in biotechnology equities and therapeutics-focused assets.